Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
Titel:
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
Auteur:
Fleischmann, Roy Mysler, Eduardo Hall, Stephen Kivitz, Alan J Moots, Robert J Luo, Zhen DeMasi, Ryan Soma, Koshika Zhang, Richard Takiya, Liza Tatulych, Svitlana Mojcik, Christopher Krishnaswami, Sriram Menon, Sujatha Smolen, Josef S